HER2/Neu Positive Recruiting Phase 3 Trials for Carvedilol (DB01136)

IndicationStatusPhase
DBCOND0037939 (HER2/Neu Positive)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03418961S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast CancerSupportive Care